Association Of Triple Negative Breast Cancer (TNBC) With BRCA-1 Mutation And Ethnicity

Authors

  • Km. Allan Wahyu Permana
  • M. Agung Yudistira Permana
  • Sayyidatun Nisa
  • Asep Sukohar Universitas Lampung

DOI:

https://doi.org/10.53089/medula.v9i3.1109

Keywords:

BRCA-1 gene mutation, ethnicity, triple negative breast cancer (TNBC)

Abstract

Breast cancer is the most common cancer suffered by women in the world, 15-20% is a subtype of triple negative breast cancer (TNBC). TNBC is a subtype of breast cancer that does not express genes for estrogen receptors (ER), progesterone receptors (PR) and HER2 overexpression, which is clinically more aggressive and unresponsive to standard therapy, thus it can worsen the prognosis. It suggests that TNBC is associated with BRCA-1 gene mutation, moreover in African-Americans. So this study aims to determine the association of TNBC with BRCA-1 gene mutation and ethnicity. International journal literature review. BRCA-1 gene mutations increased 45%-85% of the risk of breast cancer growth and 15% -25% of TNBC have BRCA-1 gene mutations which resulted in activation inefficiencies of the HR DNA repair pathway. TNBC occurred in 60% of the black race, disproportionate incidence of TNBC greater in African ethnicity compared to other ethnic groups in the world and has the worst prognosis among all races. There is asignificant association between TNBC with BRCA-1 gene mutations and ethnicity especially in African-Americans.

   

Author Biographies

Km. Allan Wahyu Permana

 

   

M. Agung Yudistira Permana

 

 

Sayyidatun Nisa

 

 

Asep Sukohar, Universitas Lampung

 

 

References

Hwang SY, Park S, Kwon Y. Recent Therapeutic Trends And Promising Targets In Triple Negative Breast Cancer. Pharmacol Ther. 2019;199:30

Arciero CA, Guo Y, Jiang R, Behera M, O’Regan R, Peng L, Et Al. ER + /HER2 + Breast Cancer Has Different Metastatic Patterns And Better Survival Than ER−/HER2 + Breast Cancer. Clin Breast Cancer . 2019;19(4):236–45.

Sibbering M, Courtney CA. Management Of Breast Cancer: Basic Principles. Surg (United Kingdom). 2019;37(3):157–63.

Khan F, Esnakula A, Ricks-Santi LJ, Zafar R, Kanaan Y, Naab T. Loss Of PTEN In High Grade Advanced Stage Triple Negative Breast Ductal Cancers In African American Women. Pathol Res Pract. 2018;214(5):673–8.

Sørlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Et Al. Repeated Observation Of Breast Tumor Subtypes In Independent Gene Expression Data Sets. Proc Natl Acad Sci. 2003;100(14):8418–23.

Sporikova Z, Koudelakova V, Trojanec R, Hajduch M. Genetic Markers In Triple-Negative Breast Cancer. Clin Breast Cancer [Internet]. 2018;18(5):E841–50. A

Amit Gupta, Jyotika Jain, Ajay Kumar, Sunil Kumar NW. TRIPLE NEGATIVE BREAST CANCER- AN OVERVIEW AND REVIEW OF LITERATURE. Asian J Medi Cal Sci. 2012;3(2):16–20.

Guney Eskiler G, Cecener G, Egeli U, Tunca B. Triple Negative Breast Cancer: New Therapeutic Approaches And BRCA Status. Apmis. 2018;126(5):371–9.

Chen H, Wu J, Zhang Z, Tang Y, Li X. Association Between BRCA Status And Triple-Negative Breast Cancer : A. Front Pharmacol. 2018;9(August):1–8.

Amir Mehrgou MA. The Importance Of BRCA1 And BRCA2 Genes Mutations In Breast Cancer Development. Med J Islam Repub Iran. 2016;30(363):1–12.

Brewster AM, Chavez-Macgregor M, Brown P. Epidemiology, Biology, And Treatment Of Triple-Negative Breast Cancer In Women Of African Ancestry. Lancet Oncol. 2014;15(13):E625–34.

JENNIFER J. GAO SMS. Luminal A Breast Cancer And Molecular Assays : A Review. Lancet Oncol. 2018;23:556–65.

Hashmi AA, Aijaz S, Khan SM, Mahboob R, Irfan M, Zafar NI, Et Al. Prognostic Parameters Of Luminal A And Luminal B Intrinsic Breast Cancer Subtypes Of Pakistani Patients. World J Surg Oncol. 2018;16(1):1–6.

Nikhilesh B, Col L, Patni P, Col L, Agarwal A, Khan CMA, Et Al. Sciencedirect Prevalence Of Molecular Subtypes Of Invasive Breast Cancer : A Retrospective Study. 1(0):4–8.

Fragomeni SM, Sciallis A, Jeruss JS, Unit BC, Arbor A, Arbor A. Molecular Subtypes And Local-Regional Control Of Breast Cancer. Surg Oncol Clin N Am. 2018;27(1):95–120.

Armstrong N, Ryder S, Forbes C, Ross J. A Systematic Review Of The International Prevalence Of BRCA Mutation In Breast Cancer. Clin Epidemiol. 2019;11:543–561.

Greenup R, Buchanan A, Lorizio W, Rhoads K, Chan S, Leedom T, Et Al. Prevalence Of BRCA Mutations Among Women With Triple-Negative Breast Cancer (TNBC) In A Genetic Counseling Cohort. Ann Surg Oncol. 2013;20(10):3254–8.

Zhu Y, Wu J, Zhang C, Sun S, Zhang J, Liu W. BRCA Mutations And Survival In Breast Cancer : An Updated Systematic Review And Meta-Analysis. Oncotarget. 2016;7(43):70113–27.

Yadav S, Ladkany R, Yadav D, Alhalabi O, Khaddam S, Isaac D, Et Al. Impact Of BRCA Mutation Status On Survival Of Women With Triple-Negative Breast Cancer. Clin Breast Cancer. 2018;18(5):E1229–35.

Hartman AR, Kaldate RR, Sailer LM, Painter L, Grier CE, Endsley RR, Et Al. Prevalence Of BRCA Mutations In An Unselected Population Of Triple-Negative Breast Cancer. Cancer. 2012;118(11):2787–95.

Young SR, Pilarski RT, Donenberg T, Shapiro C, Hammond LS, Miller J, Et Al. The Prevalence Of BRCA1 Mutations Among Young Women With Triple-Negative Breast Cancer. BMC Cancer. 2009;9:1–5.

Robertson L, Hanson H, Seal S, Warren-Perry M, Hughes D, Howell I, Et Al. BRCA1 Testing Should Be Offered To Individuals With Triple-Negative Breast Cancer Diagnosed Below 50 Years. Br J Cancer. 2012;106(6):1234–8.

Engel C, Rhiem K, Hahnen E, Loibl S, Weber KE, Seiler S, Et Al. Prevalence Of Pathogenic BRCA1 / 2 Germline Mutations Among 802 Women With Unilateral Triple-Negative Breast Cancer Without Family Cancer History. BMC Cancer. 2018;18:4–9.

Akinyemiju T, Xavier J, Altekruse SF. Breast Cancer Survival In African-American Women By Hormone Receptor Subtypes. Breast Cancer Res Treat. 2015;

Jiagge E, Jibril AS, Chitale D, Bensenhaver JM, Awuah B, Hoenerhoff M, Et Al. Comparative Analysis Of Breast Cancer Phenotypes In African American , White American , And West Versus East African Patients : Correlation Between African Ancestry And Triple- Negative Breast Cancer. Ann Surg Oncol. 2016;1–7.

Newman LA. Breast Cancer Disparities. High-Risk Breast Cancer And African Ancestry. Surg Oncol Clin N Am. 2014;23(3):579–92.

Gorodetska I, Kozeretska I, Dubrovska A. BRCA Genes: The Role In Genome Stability, Cancer Stemness And Therapy Resistance. J Cancer. 2019;10(9):2109–27.

Sharma P. Biology And Management Of Patients With Triple-Negative Breast Cancer. Oncologist. 2016;21(9):1050–62.

Sheppard VB, Cavalli LR, Dash C, Kanaan YM, Dilawari AA, Horton S, Et Al. Correlates Of Triple Negative Breast Cancer And Chemotherapy Patterns In Black And White Women With Breast Cancer. Clin Breast Cancer. 2017

Liu Q, Ambrosone CB, Zhao H, Kushi LH, Kwan ML. Early ‐ Onset Triple ‐ Negative Breast Cancer In Multiracial / Ethnic Populations : Distinct Trends Of Prevalence Of Truncation Mutations. Cancer Med. 2019;(December 2018):1–9.

Ma CX. Differences In The Mutational Landscape Of Triple-Negative Breast Cancer In African Americans And Caucasians. Breast Cancer Res Treat. 2016;

Gupta I, Sareyeldin RM, Al-Hashimi I, Al-Thawadi HA. Triple Negative Breast Cancer Profile , From Gene To Microrna , In Relation To Ethnicity. Cancers (Basel). 2019;11(363):1–25.

Scott LC. Update On Triple-Negative Breast Cancer Disparities For The United States : A Population-Based Study From The United States Cancer Statistics Database , 2010 Through 2014. Cancer. 2019;1–6.

Published

2024-05-24

How to Cite

Permana, K. A. W., Permana, M. A. Y., Nisa, S., & Sukohar, A. (2024). Association Of Triple Negative Breast Cancer (TNBC) With BRCA-1 Mutation And Ethnicity. Medical Profession Journal of Lampung, 9(3), 398-403. https://doi.org/10.53089/medula.v9i3.1109

Issue

Section

Artikel